PUBLISHER: TechSci Research | PRODUCT CODE: 1949512
PUBLISHER: TechSci Research | PRODUCT CODE: 1949512
Whole Genome Sequencing Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product & Service, By Type, By Workflow, By Application, By End User, By Region & Competition, 2021-2031F
We offer 8 hour analyst time for an additional research. Please contact us for the details.
The Global Whole Genome Sequencing Market is projected to expand from USD 2.18 Billion in 2025 to USD 4.51 Billion by 2031, registering a CAGR of 12.88%. Whole Genome Sequencing (WGS) serves as an exhaustive laboratory technique that deciphers an organism's entire DNA sequence, encompassing both coding and non-coding areas within a single process. Growth in this sector is largely underpinned by the dramatic decrease in sequencing expenses and the escalating need for precision medicine to enhance oncology and rare genetic disorder diagnostics. For example, the UK Biobank successfully coordinated the thorough analysis of whole genome sequences for roughly 490,640 participants in 2025, highlighting the scalability necessary for extensive population genomics.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 2.18 Billion |
| Market Size 2031 | USD 4.51 Billion |
| CAGR 2026-2031 | 12.88% |
| Fastest Growing Segment | Hospitals & Clinics |
| Largest Market | North America |
Nevertheless, a major obstacle hindering market progression is the difficulty associated with handling and archiving the colossal amounts of data produced by high-throughput systems. The necessity for sophisticated computational infrastructure to analyze, secure, and interpret petabytes of genomic data imposes a financial and technical hurdle that limits widespread implementation in clinical environments with constrained resources.
Market Driver
The significant reduction in sequencing costs and consumables acts as a major driver for market expansion, making high-throughput platforms accessible to facilities other than exclusive research institutes. Advancements in sequencing architecture are rapidly lowering prices, permitting laboratories to transition from targeted panels to whole genome workflows, thereby attaining superior diagnostic results at reduced operational costs. According to a February 2025 press release titled 'Ultima Genomics Increases Output by Over 50%', the commercial introduction of the UG 100 Solaris system reduced sequencing costs to $0.24 per million reads, effectively facilitating an $80 genome. This trend of falling prices lowers the financial threshold for clinical implementation, enabling healthcare systems to incorporate thorough genomic profiling into standard diagnostics for oncology and genetic diseases without sacrificing accuracy or coverage depth.
Simultaneously, the increase in government-sponsored population genomics projects is creating significant demand for extensive sequencing capabilities. Countries are making substantial investments in national biobanking initiatives to gather diverse genetic information, which hastens drug development and the application of precision medicine across various demographic groups. In February 2025, the National Institutes of Health announced in 'All of Us Adds Data from 50% More Participants' that the program had broadened its research dataset to encompass details from over 633,000 participants, highlighting the immense scale of data generation mandated by federal directives. This pattern is observed worldwide as initiatives strive to enlist diverse groups for longitudinal research; for example, Our Future Health achieved a milestone of 2.5 million volunteers in 2025, further demonstrating the swift growth of national genomic resources for biomedical study.
Market Challenge
The formidable task of administering and archiving vast quantities of genomic data currently serves as a major constraint on the Global Whole Genome Sequencing Market. Although the expense of producing raw sequence data has decreased, the costs linked to the downstream bioinformatic infrastructure required to process, store, and protect this data have increased. This results in a substantial bottleneck where the technical ability to sequence DNA exceeds the capacity to efficiently maintain the generated datasets, thereby stopping smaller healthcare institutions from utilizing these technologies.
As reported by the Global Alliance for Genomics and Health in 2025, the organization's associated infrastructure technologies supported the processing of over 10 petabytes of genomic data. Handling information of this magnitude demands enterprise-grade storage systems and high-performance computing environments, which are frequently too costly for clinical settings with limited resources. Consequently, the significant capital and operational expenses necessary for data stewardship directly impede the wider adoption of whole genome sequencing in standard medical practice, restricting market expansion primarily to well-financed research hubs.
Market Trends
The incorporation of Artificial Intelligence for Genomic Data Analysis is fundamentally transforming bioinformatic processes by substituting traditional CPU-based workflows with accelerated GPU-focused architectures. This transition tackles the crucial bottleneck of secondary analysis, where the pace of variant calling and alignment has traditionally been slower than raw data generation. By employing deep learning algorithms, laboratories can now analyze sequence reads with exceptional speed, allowing for near real-time diagnostic conclusions that are vital for urgent clinical care. For instance, NVIDIA announced in November 2024 via their 'Discover New Biological Insights with Accelerated Pangenome Alignment' release that their Parabricks v4.4 software accomplished end-to-end 30x whole genome sequencing analysis in under 30 minutes on a single-GPU system, drastically reducing the time from sample collection to results.
Concurrently, the market is observing a significant shift toward the Adoption of Hybrid and Long-Read Sequencing Technologies to address complex genomic areas that standard short-read platforms cannot access. Researchers are increasingly leveraging long-read abilities to thoroughly define structural variants, large insertions, and repetitive elements, effectively bridging gaps in reference assemblies and enhancing diagnostic outcomes for rare diseases. This technical progression is demonstrated by the swift adoption of high-throughput long-read systems that offer full genomic visibility surpassing legacy method limitations; according to Pacific Biosciences' January 2025 '2024 Annual Report' update, data output from the company's sequencers increased by 81% in 2024, indicating growing demand for high-fidelity reads in advanced genomic research.
Key Market Players
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- Oxford Nanopore Technologies plc.
- Pacific Biosciences of California, Inc.
- BGI Group
- QIAGEN N.V.
- Agilent Technologies, Inc.
- ProPhase Labs, Inc.
- Psomagen, Inc
- Azenta US Inc.
Report Scope
In this report, the Global Whole Genome Sequencing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Whole Genome Sequencing Market, By Product & Service
- Instruments
- Consumables
- Services
Whole Genome Sequencing Market, By Type
- Large Whole Genome Sequencing
- Small Whole Genome Sequencing
Whole Genome Sequencing Market, By Workflow
- Pre-sequencing
- Sequencing
- Data Analysis
Whole Genome Sequencing Market, By Application
- Human Whole Genome Sequencing
- Plant Whole Genome Sequencing
- Animal Whole Genome Sequencing
- Microbial Whole Genome Sequencing
Whole Genome Sequencing Market, By End User
- Academic & Research Institutes
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Others
Whole Genome Sequencing Market, By Region
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Whole Genome Sequencing Market.
Available Customizations:
Global Whole Genome Sequencing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
- 1.1. Market Definition
- 1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations
2. Research Methodology
- 2.1. Objective of the Study
- 2.2. Baseline Methodology
- 2.3. Key Industry Partners
- 2.4. Major Association and Secondary Sources
- 2.5. Forecasting Methodology
- 2.6. Data Triangulation & Validation
- 2.7. Assumptions and Limitations
3. Executive Summary
- 3.1. Overview of the Market
- 3.2. Overview of Key Market Segmentations
- 3.3. Overview of Key Market Players
- 3.4. Overview of Key Regions/Countries
- 3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Whole Genome Sequencing Market Outlook
- 5.1. Market Size & Forecast
- 5.1.1. By Value
- 5.2. Market Share & Forecast
- 5.2.1. By Product & Service (Instruments, Consumables, Services)
- 5.2.2. By Type (Large Whole Genome Sequencing, Small Whole Genome Sequencing)
- 5.2.3. By Workflow (Pre-sequencing, Sequencing, Data Analysis)
- 5.2.4. By Application (Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing, Microbial Whole Genome Sequencing)
- 5.2.5. By End User (Academic & Research Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others)
- 5.2.6. By Region
- 5.2.7. By Company (2025)
- 5.3. Market Map
6. North America Whole Genome Sequencing Market Outlook
- 6.1. Market Size & Forecast
- 6.1.1. By Value
- 6.2. Market Share & Forecast
- 6.2.1. By Product & Service
- 6.2.2. By Type
- 6.2.3. By Workflow
- 6.2.4. By Application
- 6.2.5. By End User
- 6.2.6. By Country
- 6.3. North America: Country Analysis
- 6.3.1. United States Whole Genome Sequencing Market Outlook
- 6.3.1.1. Market Size & Forecast
- 6.3.1.1.1. By Value
- 6.3.1.2. Market Share & Forecast
- 6.3.1.2.1. By Product & Service
- 6.3.1.2.2. By Type
- 6.3.1.2.3. By Workflow
- 6.3.1.2.4. By Application
- 6.3.1.2.5. By End User
- 6.3.1.1. Market Size & Forecast
- 6.3.2. Canada Whole Genome Sequencing Market Outlook
- 6.3.2.1. Market Size & Forecast
- 6.3.2.1.1. By Value
- 6.3.2.2. Market Share & Forecast
- 6.3.2.2.1. By Product & Service
- 6.3.2.2.2. By Type
- 6.3.2.2.3. By Workflow
- 6.3.2.2.4. By Application
- 6.3.2.2.5. By End User
- 6.3.2.1. Market Size & Forecast
- 6.3.3. Mexico Whole Genome Sequencing Market Outlook
- 6.3.3.1. Market Size & Forecast
- 6.3.3.1.1. By Value
- 6.3.3.2. Market Share & Forecast
- 6.3.3.2.1. By Product & Service
- 6.3.3.2.2. By Type
- 6.3.3.2.3. By Workflow
- 6.3.3.2.4. By Application
- 6.3.3.2.5. By End User
- 6.3.3.1. Market Size & Forecast
- 6.3.1. United States Whole Genome Sequencing Market Outlook
7. Europe Whole Genome Sequencing Market Outlook
- 7.1. Market Size & Forecast
- 7.1.1. By Value
- 7.2. Market Share & Forecast
- 7.2.1. By Product & Service
- 7.2.2. By Type
- 7.2.3. By Workflow
- 7.2.4. By Application
- 7.2.5. By End User
- 7.2.6. By Country
- 7.3. Europe: Country Analysis
- 7.3.1. Germany Whole Genome Sequencing Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.1.1. By Value
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Product & Service
- 7.3.1.2.2. By Type
- 7.3.1.2.3. By Workflow
- 7.3.1.2.4. By Application
- 7.3.1.2.5. By End User
- 7.3.1.1. Market Size & Forecast
- 7.3.2. France Whole Genome Sequencing Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.1.1. By Value
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Product & Service
- 7.3.2.2.2. By Type
- 7.3.2.2.3. By Workflow
- 7.3.2.2.4. By Application
- 7.3.2.2.5. By End User
- 7.3.2.1. Market Size & Forecast
- 7.3.3. United Kingdom Whole Genome Sequencing Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.1.1. By Value
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Product & Service
- 7.3.3.2.2. By Type
- 7.3.3.2.3. By Workflow
- 7.3.3.2.4. By Application
- 7.3.3.2.5. By End User
- 7.3.3.1. Market Size & Forecast
- 7.3.4. Italy Whole Genome Sequencing Market Outlook
- 7.3.4.1. Market Size & Forecast
- 7.3.4.1.1. By Value
- 7.3.4.2. Market Share & Forecast
- 7.3.4.2.1. By Product & Service
- 7.3.4.2.2. By Type
- 7.3.4.2.3. By Workflow
- 7.3.4.2.4. By Application
- 7.3.4.2.5. By End User
- 7.3.4.1. Market Size & Forecast
- 7.3.5. Spain Whole Genome Sequencing Market Outlook
- 7.3.5.1. Market Size & Forecast
- 7.3.5.1.1. By Value
- 7.3.5.2. Market Share & Forecast
- 7.3.5.2.1. By Product & Service
- 7.3.5.2.2. By Type
- 7.3.5.2.3. By Workflow
- 7.3.5.2.4. By Application
- 7.3.5.2.5. By End User
- 7.3.5.1. Market Size & Forecast
- 7.3.1. Germany Whole Genome Sequencing Market Outlook
8. Asia Pacific Whole Genome Sequencing Market Outlook
- 8.1. Market Size & Forecast
- 8.1.1. By Value
- 8.2. Market Share & Forecast
- 8.2.1. By Product & Service
- 8.2.2. By Type
- 8.2.3. By Workflow
- 8.2.4. By Application
- 8.2.5. By End User
- 8.2.6. By Country
- 8.3. Asia Pacific: Country Analysis
- 8.3.1. China Whole Genome Sequencing Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.1.1. By Value
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Product & Service
- 8.3.1.2.2. By Type
- 8.3.1.2.3. By Workflow
- 8.3.1.2.4. By Application
- 8.3.1.2.5. By End User
- 8.3.1.1. Market Size & Forecast
- 8.3.2. India Whole Genome Sequencing Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.1.1. By Value
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Product & Service
- 8.3.2.2.2. By Type
- 8.3.2.2.3. By Workflow
- 8.3.2.2.4. By Application
- 8.3.2.2.5. By End User
- 8.3.2.1. Market Size & Forecast
- 8.3.3. Japan Whole Genome Sequencing Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.1.1. By Value
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Product & Service
- 8.3.3.2.2. By Type
- 8.3.3.2.3. By Workflow
- 8.3.3.2.4. By Application
- 8.3.3.2.5. By End User
- 8.3.3.1. Market Size & Forecast
- 8.3.4. South Korea Whole Genome Sequencing Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.1.1. By Value
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Product & Service
- 8.3.4.2.2. By Type
- 8.3.4.2.3. By Workflow
- 8.3.4.2.4. By Application
- 8.3.4.2.5. By End User
- 8.3.4.1. Market Size & Forecast
- 8.3.5. Australia Whole Genome Sequencing Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.1.1. By Value
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Product & Service
- 8.3.5.2.2. By Type
- 8.3.5.2.3. By Workflow
- 8.3.5.2.4. By Application
- 8.3.5.2.5. By End User
- 8.3.5.1. Market Size & Forecast
- 8.3.1. China Whole Genome Sequencing Market Outlook
9. Middle East & Africa Whole Genome Sequencing Market Outlook
- 9.1. Market Size & Forecast
- 9.1.1. By Value
- 9.2. Market Share & Forecast
- 9.2.1. By Product & Service
- 9.2.2. By Type
- 9.2.3. By Workflow
- 9.2.4. By Application
- 9.2.5. By End User
- 9.2.6. By Country
- 9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Whole Genome Sequencing Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.1.1. By Value
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Product & Service
- 9.3.1.2.2. By Type
- 9.3.1.2.3. By Workflow
- 9.3.1.2.4. By Application
- 9.3.1.2.5. By End User
- 9.3.1.1. Market Size & Forecast
- 9.3.2. UAE Whole Genome Sequencing Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.1.1. By Value
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Product & Service
- 9.3.2.2.2. By Type
- 9.3.2.2.3. By Workflow
- 9.3.2.2.4. By Application
- 9.3.2.2.5. By End User
- 9.3.2.1. Market Size & Forecast
- 9.3.3. South Africa Whole Genome Sequencing Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.1.1. By Value
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Product & Service
- 9.3.3.2.2. By Type
- 9.3.3.2.3. By Workflow
- 9.3.3.2.4. By Application
- 9.3.3.2.5. By End User
- 9.3.3.1. Market Size & Forecast
- 9.3.1. Saudi Arabia Whole Genome Sequencing Market Outlook
10. South America Whole Genome Sequencing Market Outlook
- 10.1. Market Size & Forecast
- 10.1.1. By Value
- 10.2. Market Share & Forecast
- 10.2.1. By Product & Service
- 10.2.2. By Type
- 10.2.3. By Workflow
- 10.2.4. By Application
- 10.2.5. By End User
- 10.2.6. By Country
- 10.3. South America: Country Analysis
- 10.3.1. Brazil Whole Genome Sequencing Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.1.1. By Value
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Product & Service
- 10.3.1.2.2. By Type
- 10.3.1.2.3. By Workflow
- 10.3.1.2.4. By Application
- 10.3.1.2.5. By End User
- 10.3.1.1. Market Size & Forecast
- 10.3.2. Colombia Whole Genome Sequencing Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.1.1. By Value
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Product & Service
- 10.3.2.2.2. By Type
- 10.3.2.2.3. By Workflow
- 10.3.2.2.4. By Application
- 10.3.2.2.5. By End User
- 10.3.2.1. Market Size & Forecast
- 10.3.3. Argentina Whole Genome Sequencing Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.1.1. By Value
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Product & Service
- 10.3.3.2.2. By Type
- 10.3.3.2.3. By Workflow
- 10.3.3.2.4. By Application
- 10.3.3.2.5. By End User
- 10.3.3.1. Market Size & Forecast
- 10.3.1. Brazil Whole Genome Sequencing Market Outlook
11. Market Dynamics
- 11.1. Drivers
- 11.2. Challenges
12. Market Trends & Developments
- 12.1. Merger & Acquisition (If Any)
- 12.2. Product Launches (If Any)
- 12.3. Recent Developments
13. Global Whole Genome Sequencing Market: SWOT Analysis
14. Porter's Five Forces Analysis
- 14.1. Competition in the Industry
- 14.2. Potential of New Entrants
- 14.3. Power of Suppliers
- 14.4. Power of Customers
- 14.5. Threat of Substitute Products
15. Competitive Landscape
- 15.1. Illumina, Inc.
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
- 15.2. Thermo Fisher Scientific Inc.
- 15.3. Oxford Nanopore Technologies plc.
- 15.4. Pacific Biosciences of California, Inc.
- 15.5. BGI Group
- 15.6. QIAGEN N.V.
- 15.7. Agilent Technologies, Inc.
- 15.8. ProPhase Labs, Inc.
- 15.9. Psomagen, Inc
- 15.10. Azenta US Inc.
16. Strategic Recommendations
17. About Us & Disclaimer
